Search

Search Constraints

You searched for: Author/Creator Law, Arjun Datt

Search Results

1. Allogeneic hematopoietic stem cell transplantation in patients with therapy‐related hematologic malignancies developing after multiple myeloma. (7th February 2022)

2. High incidence but low mortality of EBV-reactivation and PTLD after alloHCT using ATG and PTCy for GVHD prophylaxis. Issue 13 (9th November 2020)

3. Lower dose of ATG combined with post-transplant cyclophosphamide for HLA matched RIC alloHCT is associated with effective control of GVHD and less viral infections. Issue 14 (6th December 2021)

4. Outcomes of therapy‐related acute lymphoblastic leukemia in adults after allogeneic stem cell transplantation. (18th March 2020)

6. Prolactin, a potential biomarker for chronic GVHD activity. (26th October 2020)

7. Prolactin, a potential biomarker for chronic GVHD activity. (26th October 2020)

8. Reduced intensity allogeneic stem cell transplant with anti‐thymocyte globulin and post‐transplant cyclophosphamide in acute myeloid leukemia. (9th September 2019)

9. Reduced‐intensity conditioning allogeneic transplant with dual T‐cell depletion in myelofibrosis. (30th September 2019)

10. Relationship between certain HLA alleles and the risk of cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantation. Issue 4 (13th July 2022)